Skip to main content

#

Melan-ep2 cell line

Melan-ep2 cell line

Organism: Mouse

Tissue: Skin

Disease: Hermansky-Pudlak syndrome

Model: Immortalised non-cancerous cell lines

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Elena Sviderskaya

Institute: St. George's University London

Primary Citation: Suzuki T, et al. Nat Gene. 2002 Mar;30(3):321-4. PMID: 11836498

Tool Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Melan-ep2 cell line
  • Cancer: N/A
  • Research fields: Tissue-specific biology
  • Organism: Mouse
  • Gender: Unspecified
  • Tissue: Skin
  • Disease: Hermansky-Pudlak syndrome
  • Morphology: Small, oval-fusiform
  • Growth properties: Adherent
  • Model: Immortalised non-cancerous cell lines
  • Crispr: No
  • Conditional: No
  • Description: The melan-ep1 and -ep2 cell lines are immortal melanocyte cell lines derived from neonatal Hps1ep/Hps1ep C57BL/6J mice. These cell lines lack ep (pale ear), a subunit of the biogenesis of lysosome-related organelles complex 3 (BLOC-3). BLOC-3 is involved in cargo recycling from melanosomes. Pathogenic variants in the human ortholog of ep, HPS1, cause a form of Hermansky-Pudlak syndrome (HPS), HPS type 1. HPS is a group of disorders characterised by hypopigmentation, bleeding tendency and other variable symptoms. These cells are a useful model for HPS and for the study of trafficking of cargoes towards lysosome-related organelles.
  • Application: Melanocyte cell biology
  • Biosafety level: BSL1

Applications

  • Application: Melanocyte cell biology

Handling

  • Growth medium: RPMI + FBS (10%) + TPA (200 nM) + cholera toxin (CT) (200 pM)
  • Storage conditions: liquid N2

References

  • Suzuki T, et al. Nat Gene. 2002 Mar
  • 30(3):321-4. PMID: 11836499

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.